NLS Pharmaceutics Ltd - Warrants (25/09/2025) Accounts Payable

NLS Pharmaceutics Ltd - Warrants (25/09/2025) (NLSPW) currently reports a accounts payable of $1M as of June 2025. That compares with $4.6M in the prior-year period — down 77.7% year over year. Use the charts on this page to explore NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s accounts payable history and peer comparisons.

NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s accounts payable decreased from $4.6M to $1M — a 77.7% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NLS Pharmaceutics Ltd - Warrants (25/09/2025) reported $1M in accounts payable as of June 2025. That compares with $4.6M in the prior-year period — down 77.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NLS Pharmaceutics Ltd - Warrants (25/09/2025), and consider following NLSPW for alerts when major investors trade the stock.

NLS Pharmaceutics Ltd - Warrants (25/09/2025) is classified in the Healthcare sector. On accounts payable, it currently shows $1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NLSPW with unrelated industries.